These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37089961)

  • 41. Predictive models for designing potent tyrosine kinase inhibitors in chronic myeloid leukemia for understanding its molecular mechanism of resistance by molecular docking and dynamics simulations.
    Melge AR; Kumar LG; K P; Nair SV; K M; C GM
    J Biomol Struct Dyn; 2019 Nov; 37(18):4747-4766. PubMed ID: 30580670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benchmarking 2D/3D/MD-QSAR Models for Imatinib Derivatives: How Far Can We Predict?
    Kyaw Zin PP; Borrel A; Fourches D
    J Chem Inf Model; 2020 Jul; 60(7):3342-3360. PubMed ID: 32623886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design of potential anti-tumor PARP-1 inhibitors by QSAR and molecular modeling studies.
    Abbasi-Radmoghaddam Z; Riahi S; Gharaghani S; Mohammadi-Khanaposhtanai M
    Mol Divers; 2021 Feb; 25(1):263-277. PubMed ID: 32140890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2D- and 3D-QSAR Modeling of Imidazole-Based Glutaminyl Cyclase Inhibitors.
    Al-Attraqchi OHA; Venugopala KN
    Curr Comput Aided Drug Des; 2020; 16(6):682-697. PubMed ID: 31533602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative QSAR studies on peptide deformylase inhibitors.
    Lee JY; Doddareddy MR; Cho YS; Choo H; Koh HY; Kang JH; No KT; Pae AN
    J Mol Model; 2007 May; 13(5):543-58. PubMed ID: 17333308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
    Ahmadi S; Habibpour E
    Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
    He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
    Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents.
    Hadni H; Elhallaoui M
    Heliyon; 2020 Apr; 6(4):e03580. PubMed ID: 32322700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition.
    Yadav D; Nath Mishra B; Khan F
    J Biomol Struct Dyn; 2019 Sep; 37(14):3822-3837. PubMed ID: 30261824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors.
    Rebehmed J; Barbault F; Teixeira C; Maurel F
    J Comput Aided Mol Des; 2008 Nov; 22(11):831-41. PubMed ID: 18506577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
    Sharma MC
    Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
    Buolamwini JK; Assefa H
    J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
    Wang Y; Guo H; Tang G; He Q; Zhang Y; Hu Y; Wang Y; Lin Z
    Comput Biol Chem; 2019 Jun; 80():234-243. PubMed ID: 31009872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.
    Lu S; Liu HC; Chen YD; Yuan HL; Sun SL; Gao YP; Yang P; Zhang L; Lu T
    Int J Mol Sci; 2011; 12(12):8713-39. PubMed ID: 22272100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitors.
    Ashraf N; Asari A; Yousaf N; Ahmad M; Ahmed M; Faisal A; Saleem M; Muddassar M
    Front Chem; 2022; 10():1003816. PubMed ID: 36405310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
    Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
    Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-based QSAR, molecule design and bioassays of protease-activated receptor 1 inhibitors.
    Zhong W; Liu P; Zhang Q; Li D; Lin J
    J Biomol Struct Dyn; 2017 Oct; 35(13):2853-2867. PubMed ID: 27809674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved 3D-QSAR prediction by multiple-conformational alignment: A case study on PTP1B inhibitors.
    Zhang X; Mao J; Li W; Koike K; Wang J
    Comput Biol Chem; 2019 Dec; 83():107134. PubMed ID: 31629257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.